Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Jiang, Junfeng ^a,b   Zhang, Li ^a,b   Zhou, Xingliang ^b   Chen, Xi ^b   Huang, Guanyi ^b   Li, Fengsheng ^b   Wang, Ruizhe ^b   Wu, Nancy ^b   Yan, Youzhen ^b   Tong, Chang ^b   Srivastava, Sankalp ^b   Wang, Yue ^a   Liu, Houqi ^a   Ying, Qi Long ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; CELL LINE; CRISPR CAS SYSTEM; CYTOLOGY; EMBRYONIC STEM CELL; GENE TRANSLOCATION; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; CRISPR-CAS SYSTEMS; EMBRYONIC STEM CELLS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MODELS, GENETIC; TRANSLOCATION, GENETIC;

EID: 84959019046     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21918     Document Type: Article

References (37)

1. Braude, P., Pickering, S., Flinter, F. & Ogilvie, C. M. Preimplantation genetic diagnosis. Nat Rev Genet 3, 941-953 (2002).
2. Roukos, V. & Misteli, T. The biogenesis of chromosome translocations. Nat Cell Biol 16, 293-300 (2014).
3. Fraccaro, M., Maraschio, P., Pasquali, F., Tiepolo, L., Zuffardi, O. & Giarola, A. Male infertility and 13-14 translocation. Lancet 1, 488 (1973).
4. Prasher, V. P. Presenile dementia associated with unbalanced Robertsonian translocation form of Down's syndrome. Lancet 342, 686-687 (1993).
5. Priest, J. H., Bryant, J. & Motulsky, A. G. Down's Syndrome: Trisomy and a De-Novo Translocation in a Family. Lancet 2, 411-412 (1963).
6. Eykelenboom, J. E. et al. A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins. Hum Mol Genet 21, 3374-3386 (2012).
7. Bunting, S. F. & Nussenzweig, A. End-joining, translocations and cancer. Nat Rev Cancer 13, 443-454 (2013).
8. Li, Y. et al. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature 508, 98-102 (2014).
9. Mitelman, F., Johansson, B. & Mertens, F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7, 233-245 (2007).
10. Bochtler, T. et al. Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens. J Clin Oncol 33, 1371-1378 (2015).
11. Rodriguez-Perales, S. et al. Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors. Oncogene, doi: 10.1038/onc.2015.70 (2015).
12. Schneider, A. et al. Identification of disrupted AUTS2 and EPHA6 genes by array painting in a patient carrying a de novo balanced translocation t(3;7) with intellectual disability and neurodevelopment disorder. Am J Med Genet A, doi: 10.1002/ajmg.a.37350 (2015).
13. Crippa, M. et al. New case of trichorinophalangeal syndrome-like phenotype with a de novo t(2;8)(p16.1;q23.3) translocation which does not disrupt the TRPS1 gene. BMC Med Genet 15, 52 (2014).
14. Rajkumar, A. P. et al. Analysis of t(9;17)(q33.2;q25.3) chromosomal breakpoint regions and genetic association reveals novel candidate genes for bipolar disorder. Bipolar Disord, doi: 10.1111/bdi.12239 (2014).
15. Sterneckert, J. L., Reinhardt, P. & Scholer, H. R. Investigating human disease using stem cell models. Nat Rev Genet 15, 625-639 (2014).
16. Young, R. A. Control of the embryonic stem cell state. Cell 144, 940-954 (2011).
17. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
18. Hsu, P. D., Lander, E. S. & Zhang, F. Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell 157, 1262-1278 (2014).
19. Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L. A. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31, 233-239 (2013).
20. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A. & Charpentier, E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821 (2012).
21. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
22. AbouAlaiwi, W. A., Rodriguez, I. & Nauli, S. M. Spectral karyotyping to study chromosome abnormalities in humans and mice with polycystic kidney disease. J Vis Exp 60, e3887-e3887(2012).
23. Ren, R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5, 172-183 (2005).
24. Choi, P. S. & Meyerson, M. Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun 5, 3728 (2014).
25. Maddalo, D. et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature, 516, 423-427 (2014).
26. Torres, R., Martin, M. C., Garcia, A., Cigudosa, J. C., Ramirez, J. C. & Rodriguez-Perales, S. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat Commun 5, 3964 (2014).
27. Mendjan, S. et al. NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency. Cell Stem Cell 15, 310-325 (2014).
28. Rayon, T. et al. Notch and hippo converge on Cdx2 to specify the trophectoderm lineage in the mouse blastocyst. Dev Cell 30, 410-422 (2014).
29. Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380 (2012).
30. Handoko, L. et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat Genet 43, 630-638 (2011).
31. Hughes, J. R. et al. Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet 46, 205-212 (2014).
32. Jin, F. et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503, 290-294 (2013).
33. Sexton, T. et al. Three-dimensional folding and functional organization principles of the Drosophila genome. Cell 148, 458-472 (2012).
34. van de Werken, H. J. et al. Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat Methods 9, 969-972 (2012).
35. Kuscu, C., Arslan, S., Singh, R., Thorpe, J. & Adli, M. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat Biotechnol 32, 677-683 (2014).
36. Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol 32, 670-676 (2014).
37. Hooper, M., Hardy, K., Handyside, A., Hunter, S. & Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326, 292-295 (1987).